CY1121078T1 - Ανοργανα νανοσωματιδια υψηλης πυκνοτητας για καταστροφη κυτταρων in-vivo - Google Patents

Ανοργανα νανοσωματιδια υψηλης πυκνοτητας για καταστροφη κυτταρων in-vivo

Info

Publication number
CY1121078T1
CY1121078T1 CY181101377T CY181101377T CY1121078T1 CY 1121078 T1 CY1121078 T1 CY 1121078T1 CY 181101377 T CY181101377 T CY 181101377T CY 181101377 T CY181101377 T CY 181101377T CY 1121078 T1 CY1121078 T1 CY 1121078T1
Authority
CY
Cyprus
Prior art keywords
particles
health
vivo
high density
relates
Prior art date
Application number
CY181101377T
Other languages
English (en)
Inventor
Laurent Levy
Agnès Pottier
Annabelle Rouet
Julie Marill
Corinne Devaux
Matthieu Germain
Original Assignee
Nanobiotix
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nanobiotix filed Critical Nanobiotix
Publication of CY1121078T1 publication Critical patent/CY1121078T1/el

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0038Radiosensitizing, i.e. administration of pharmaceutical agents that enhance the effect of radiotherapy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/244Lanthanides; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00Nanotechnology
    • Y10S977/902Specified use of nanostructure
    • Y10S977/904Specified use of nanostructure for medical, immunological, body treatment, or diagnosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Nanotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biophysics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Compounds Of Alkaline-Earth Elements, Aluminum Or Rare-Earth Metals (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Radiation-Therapy Devices (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Η παρούσα αίτηση σχετίζεται με νέα διεγέρσιμα σωματίδια τα οποία μπορεί να χρησιμοποιηθούν στον τομέα της υγείας. Πιο συγκεκριμένα σχετίζεται με σωματίδια τα οποία μπορεί να παράγουν ηλεκτρόνια και/ή υψηλής ενέργειας φωτόνιο όταν διεγερθούν με ιονίζουσες ακτινοβολίες όπως Ακτίνες Χ, Ακτίνες γάμμα, ραδιενεργό ισότοπο και/ή δέσμες ηλεκτρονίων, και με τις χρήσεις αυτών στην υγεία, ειδικότερα στην ανθρώπινη υγεία. Τα σωματίδια της εφεύρεσης αποτελούνται από ένα ανόργανο υλικό το οποίο περιλαμβάνει οξυγόνο, πιο συγκεκριμένα ένα οξείδιο, με το εν λόγω υλικό να έχει μία επαρκή πυκνότητα, και μπορεί να ενεργοποιηθούν in vitro, ex vivo, ή in vivo, με ελεγχόμενη εξωτερική διέγερση, για να διαταράξουν, να τροποποιήσουν ή να καταστρέψουν κύτταρα, ιστούς ή όργανα στόχους. Η εφεύρεση επίσης σχετίζεται με μεθόδους για την παραγωγή των εν λόγω σωματιδίων, και με φαρμακευτικές συνθέσεις ή συνθέσεις ιατρικών συσκευών οι οποίες τα περιέχουν.
CY181101377T 2008-06-05 2018-12-19 Ανοργανα νανοσωματιδια υψηλης πυκνοτητας για καταστροφη κυτταρων in-vivo CY1121078T1 (el)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP08157686A EP2130553A1 (en) 2008-06-05 2008-06-05 Inorganic nanoparticles of high density to destroy cells in-vivo
US6020208P 2008-06-10 2008-06-10
EP09757595.5A EP2300054B1 (en) 2008-06-05 2009-06-04 Inorganic nanoparticles of high density to destroy cells in-vivo
PCT/EP2009/056880 WO2009147214A2 (en) 2008-06-05 2009-06-04 Inorganic nanoparticles, preparation and uses thereof

Publications (1)

Publication Number Publication Date
CY1121078T1 true CY1121078T1 (el) 2019-12-11

Family

ID=39734334

Family Applications (2)

Application Number Title Priority Date Filing Date
CY20161101109T CY1118217T1 (el) 2008-06-05 2016-11-01 Ανοργανα νανοσωματιδια υψηλης πυκνοτητας για καταστροφη κυτταρων in-vivo
CY181101377T CY1121078T1 (el) 2008-06-05 2018-12-19 Ανοργανα νανοσωματιδια υψηλης πυκνοτητας για καταστροφη κυτταρων in-vivo

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CY20161101109T CY1118217T1 (el) 2008-06-05 2016-11-01 Ανοργανα νανοσωματιδια υψηλης πυκνοτητας για καταστροφη κυτταρων in-vivo

Country Status (26)

Country Link
US (1) US8845507B2 (el)
EP (4) EP2130553A1 (el)
JP (1) JP5734181B2 (el)
KR (1) KR101639281B1 (el)
CN (1) CN102056628B (el)
AU (1) AU2009254550B2 (el)
BR (1) BRPI0913410B1 (el)
CA (1) CA2727576C (el)
CY (2) CY1118217T1 (el)
DK (2) DK2300054T3 (el)
EA (1) EA023012B1 (el)
ES (2) ES2702249T3 (el)
HR (2) HRP20161465T8 (el)
HU (2) HUE040247T2 (el)
IL (1) IL209625A (el)
LT (2) LT3150227T (el)
MA (1) MA32453B1 (el)
MX (1) MX2010013322A (el)
NZ (1) NZ589888A (el)
PL (2) PL3150227T3 (el)
PT (2) PT2300054T (el)
SG (1) SG10201405288WA (el)
SI (2) SI2300054T1 (el)
TR (1) TR201819077T4 (el)
WO (1) WO2009147214A2 (el)
ZA (1) ZA201100082B (el)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004075975A2 (en) * 2003-02-24 2004-09-10 Pomper Mark E Mobile radiation treatment vehicle and method
US8657354B2 (en) 2006-05-19 2014-02-25 Breya, Llc. Mobile radiation therapy
US8459714B2 (en) 2006-05-19 2013-06-11 Breya, Llc. Mobile radiation therapy
US9399075B2 (en) 2008-12-29 2016-07-26 General Electric Company Nanoparticle contrast agents for diagnostic imaging
US8728440B2 (en) 2012-08-23 2014-05-20 General Electric Company Nanoparticulate compositions for diagnostic imaging
EP2275137A1 (en) * 2009-07-10 2011-01-19 Nanobiotix Metallic nanoparticles, preparation and uses thereof
US9585840B1 (en) 2009-07-10 2017-03-07 University Of Central Florida Research Foundation, Inc. Redox active cerium oxide nanoparticles and associated methods
CN102870235B (zh) * 2009-11-10 2016-11-23 免疫之光有限责任公司 用于从包括用于上变频的射频、微波能量和磁感应源的各种能量源产生发射光的上下变频系统
KR20180100248A (ko) 2010-04-23 2018-09-07 픽셀리전트 테크놀로지스 엘엘씨 나노결정의 합성, 캐핑 및 분산
US8920675B2 (en) 2010-10-27 2014-12-30 Pixelligent Technologies, Llc Synthesis, capping and dispersion of nanocrystals
US9359689B2 (en) 2011-10-26 2016-06-07 Pixelligent Technologies, Llc Synthesis, capping and dispersion of nanocrystals
SG11201403096VA (en) 2011-12-16 2014-07-30 Nanobiotix Nanoparticles comprising metallic and hafnium oxide materials, preparation and uses thereof
WO2013188755A2 (en) * 2012-06-14 2013-12-19 The Board Of Trustees Of The University Of Arkansas Compositions and methods for non-invasive detection and treatment of hypoxic cells in vivo
US8821838B2 (en) 2012-08-23 2014-09-02 General Electric Company Nanoparticulate compositions for diagnostic imaging
KR102225239B1 (ko) * 2013-01-25 2021-03-09 나노비오?笭? 암 치료용 이온화 방사선과 조합된 무기 나노입자 조성물
RU2015135133A (ru) * 2013-02-19 2017-03-24 Нэшенел Хелс Рисёч Инститьютс Заключенные в оболочку нанокластеры платины для противораковых химиотерапевтических средств
BR112015029853A2 (pt) 2013-05-30 2017-07-25 Nanobiotix uso de uma composição farmacêutica
MA38709A1 (fr) 2013-06-20 2018-05-31 Nanobiotix Compositions et procédés pour une utilisation en diagnostic médical
EP2886128A1 (en) 2013-12-20 2015-06-24 Nanobiotix Pharmaceutical composition comprising nanoparticles, preparation and uses thereof
EP3229776B1 (en) 2014-11-25 2023-06-28 Curadigm Sas Pharmaceutical composition combining at least two distinct nanoparticles and a pharmaceutical compound, preparation and uses thereof
JP6789960B2 (ja) 2014-11-25 2020-11-25 キュラディグム・エスアエスCuradigm Sas 医薬組成物、その調製及び使用
AR102778A1 (es) 2014-11-25 2017-03-22 Nanobiotix Composición farmacéutica, su preparación y sus usos
US11304902B2 (en) 2014-11-25 2022-04-19 Curadigm Sas Pharmaceutical compositions, preparation and uses thereof
SG11201704143YA (en) 2014-11-25 2017-06-29 Nanobiotix Pharmaceutical composition, preparation and uses thereof
EP3721887A1 (en) * 2015-01-08 2020-10-14 Purdue Research Foundation Non-toxic formulations of radio-luminescent nanoparticles for use as cancer radio-sensitizing agents
AR104806A1 (es) * 2015-05-28 2017-08-16 Nanobiotix Nanopartículas para uso como vacuna terapéutica
US11389536B2 (en) 2015-07-17 2022-07-19 BioCurity Pharmaceuticals Inc. Treatment of cancer with a combination of radiation, cerium oxide nanoparticles, and a chemotherapeutic agent
CN109010828B (zh) * 2018-10-12 2020-10-20 中国科学院高能物理研究所 一种二硫化钼/二氧化铪的复合纳米材料、其制备方法及用途
CN109616308B (zh) * 2018-11-07 2020-09-04 湖北第二师范学院 一种球形纳米氧化铱dna提取磁性粉末及其生产方法
CN109771645B (zh) * 2019-03-07 2021-08-24 广西师范大学 一种二氧化钌复合卵清蛋白纳米材料的制备及其应用
US20230211175A1 (en) * 2020-05-26 2023-07-06 Nanobiotix S.A. Nanoparticles, ionizing radiation and innovative therapeutic combinations thereof
MX2023005314A (es) * 2020-11-05 2023-05-25 Nanobiotix Composiciones de nanoparticulas para tratamiento de cancer.
US20240000940A1 (en) * 2020-12-01 2024-01-04 Nanobiotix S.A. Porous, high-z and carbon-free particles as radioenhancers
WO2024126383A1 (en) 2022-12-12 2024-06-20 Nanobiotix (Nanobiotix S.A.) Novel metal oxide nanoparticles and compositions thereof for use as radioenhancers or for visualizing biological tissue

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6287526A (ja) * 1985-10-11 1987-04-22 Akira Fujishima 抗腫瘍剤
US6645464B1 (en) 1998-07-30 2003-11-11 James F. Hainfeld Loading metal particles into cell membrane vesicles and metal particular use for imaging and therapy
JP2007514736A (ja) 2003-12-17 2007-06-07 コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ 紫外線放射ナノ粒子を用いた放射線治療および医学画像
FR2869803B1 (fr) * 2004-05-10 2006-07-28 Nanobiotix Sarl Particules activables, preparation et utilisations
US20070092927A1 (en) * 2005-06-13 2007-04-26 University Of Dayton Photocatalytic particles with directed and controlled redox activity
JP2007075696A (ja) * 2005-09-13 2007-03-29 Mitsubishi Materials Corp 多孔質光触媒膜
EP2040752A2 (en) * 2006-07-10 2009-04-01 Philips Intellectual Property & Standards GmbH Core-shell nanoparticles for thearapy and imaging purposes
EP1920784A1 (en) * 2006-11-13 2008-05-14 Koninklijke Philips Electronics N.V. Radiation sensitizers in ionizing radiation therapy and imaging

Also Published As

Publication number Publication date
CA2727576C (en) 2016-08-16
EP2130553A1 (en) 2009-12-09
EP3150227B1 (en) 2018-10-31
HUE040247T2 (hu) 2019-02-28
ES2702249T3 (es) 2019-02-28
LT3150227T (lt) 2018-12-10
PT2300054T (pt) 2016-11-11
CN102056628B (zh) 2013-07-10
MA32453B1 (fr) 2011-07-03
KR101639281B1 (ko) 2016-07-13
EP2300054A2 (en) 2011-03-30
EA201071429A1 (ru) 2011-06-30
SI3150227T1 (sl) 2019-02-28
EP2300054B1 (en) 2016-09-07
SI2300054T1 (sl) 2017-02-28
PT3150227T (pt) 2018-12-24
MX2010013322A (es) 2011-01-21
AU2009254550B2 (en) 2013-10-24
DK3150227T3 (en) 2019-01-14
WO2009147214A2 (en) 2009-12-10
NZ589888A (en) 2012-06-29
DK2300054T3 (en) 2016-12-05
CA2727576A1 (en) 2009-12-10
BRPI0913410A2 (pt) 2015-11-24
US20110213192A1 (en) 2011-09-01
JP2011524866A (ja) 2011-09-08
ZA201100082B (en) 2011-10-26
IL209625A (en) 2015-11-30
SG10201405288WA (en) 2014-10-30
TR201819077T4 (tr) 2019-01-21
LT2300054T (lt) 2016-12-27
PL3150227T3 (pl) 2019-05-31
EA023012B1 (ru) 2016-04-29
EP3461502A1 (en) 2019-04-03
AU2009254550A1 (en) 2009-12-10
HUE030669T2 (en) 2017-05-29
HRP20161465T8 (hr) 2017-04-21
HRP20161465T1 (hr) 2017-01-27
CY1118217T1 (el) 2017-06-28
PL2300054T3 (pl) 2017-04-28
IL209625A0 (en) 2011-02-28
WO2009147214A3 (en) 2010-02-25
JP5734181B2 (ja) 2015-06-17
CN102056628A (zh) 2011-05-11
HRP20181993T1 (hr) 2019-01-25
EP3150227A1 (en) 2017-04-05
KR20110028616A (ko) 2011-03-21
BRPI0913410B1 (pt) 2021-09-21
ES2602048T3 (es) 2017-02-17
US8845507B2 (en) 2014-09-30

Similar Documents

Publication Publication Date Title
CY1121078T1 (el) Ανοργανα νανοσωματιδια υψηλης πυκνοτητας για καταστροφη κυτταρων in-vivo
Esplen et al. Physics and biology of ultrahigh dose-rate (FLASH) radiotherapy: a topical review
Andreo On the clinical spatial resolution achievable with protons and heavier charged particle radiotherapy beams
Lechtman et al. Implications on clinical scenario of gold nanoparticle radiosensitization in regards to photon energy, nanoparticle size, concentration and location
CY1118600T1 (el) Μεταλλικα νανοσωματιδια, παρασκευη και χρησεις αυτων
CY1121838T1 (el) Συνθεσεις που περιλαμβανουν νανοσωματιδια οξειδιου του αφνιου (iv) ή οξειδιου του ρηνιου (iv) σε συνδυασμο με ιονιζουσες ακτινοβολιες για αντιμετωπιση καρκινου
Nakamura et al. Antitumor effect of boron nitride nanotubes in combination with thermal neutron irradiation on BNCT
CA2946386A1 (en) Tumor imaging using photon-emitting phosphors having therapeutic properties
Oppelt et al. Comparison study of in vivo dose response to laser-driven versus conventional electron beam
WO2014116665A3 (en) Directed x-ray fields for tomosynthesis
Martins et al. Prompt gamma spectroscopy for range control with CeBr3
WO2005023367A3 (en) X-ray and gamma ray emitting temporary high dose rate brachyterapy source
Kwon et al. Spatial distributions of dose enhancement around a gold nanoparticle at several depths of proton Bragg peak
CL2020000941A1 (es) Dispositivo mejorado para la esterilizacion de bolsas flexibles mediante irradiacion por haz de electrones y procedimiento de esterilizacion de las mismas
Cai et al. Enhanced DNA damage induced by secondary electron emission from a tantalum surface exposed to soft X rays
WO2014033112A3 (de) Dosismessvorrichtung
HRP20190848T1 (hr) Pripravci namijenjeni upotrebi u onkologiji
HRP20191272T1 (hr) Pripravci koji sadrže nano čestice hafnium (iv) oksida ili renij (iv) oksida u kombinaciji s ionizirajućim zračenjem za liječenje raka
Khosravi et al. Target dose enhancement factor alterations related to interaction between the photon beam energy and gold nanoparticles' size in external radiotherapy: using Monte Carlo method.
Gopee-Ramanan et al. Basic X-Ray Physics
Safronov et al. Magnetite nanoparticles for nonradionuclide brachytherapy
Ishak-Boushakia et al. Energy Responses of Radiophotoluminescent Glass Dosimeters to Photons and Electrons Used in Radiotherapy Treatments
Jasim et al. The Effect of Doubled Concentration of Nanoparticles with Gamma-Rays Energy as Simulation Radiotherapy in Lung Cancer.
Legorreta G et al. Conditioning for bone marrow transplantation by using total body irradiation
LT2019075A (lt) Lazerinis jonizuojančios spinduliuotės didelės momentinės dozės generavimo įrenginys